Physician
Bond Pediatrics LTD
Bond Pediatrics LTD was paid $2.84M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoBOND PEDIATRICS LTD
LAS VEGAS, NV 89148
LAS VEGAS, NV 89148
33aNPI1699014365assigned 01/31/2013
33bProvider typePediatrics Physician
28Total paid$2.84M
24GClaims86,270
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Nevada
Rank by total paid#18 of 267
Median peer was paid$116K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,226 | $333K | |
| 2019 | 14,839 | $531K | |
| 2020 | 9,541 | $377K | |
| 2021 | 11,922 | $441K | |
| 2022 | 8,531 | $276K | |
| 2023 | 11,963 | $347K | |
| 2024incomplete | 19,248 | $536K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 15,596 | 12,827 | $863K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 13% | 4,753 | 3,922 | $363K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 13% | 4,330 | 3,961 | $361K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 12% | 9,090 | 8,366 | $344K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 9.9% | 3,377 | 3,124 | $281K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.5% | 2,318 | 2,161 | $212K |
| 92587 | 2.4% | 4,788 | 4,440 | $68K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.0% | 3,669 | 3,288 | $57K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 1,871 | 1,636 | $57K |
| 99401 | 2.0% | 2,166 | 2,009 | $57K | |
| 99188 | 1.8% | 4,993 | 4,638 | $50K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 4,574 | 4,126 | $43K |
48 more codes
| 92015 | Determination of refractive state | <1% | 713 | $21K |
| 92567 | <1% | 1,285 | $13K | |
| 94664 | <1% | 786 | $10K | |
| 94667 | <1% | 500 | $8K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 501 | $6K |
| 96127 | <1% | 1,196 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 205 | $4K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 605 | $4K |
| 99383 | <1% | 28 | $3K | |
| 99460 | <1% | 54 | $3K | |
| 94760 | <1% | 1,324 | $3K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 34 | $1K |
| 87807 | <1% | 162 | $1K | |
| 99381 | <1% | 13 | $1K | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 496 | $984.54 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 497 | $644.38 |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | <1% | 522 | $418.44 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 34 | $385.56 |
| 36416 | <1% | 140 | $368.41 | |
| 84030 | <1% | 125 | $273.87 | |
| 90461 | <1% | 15 | $251.42 | |
| 90620 | <1% | 22 | $250.00 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 16 | $73.44 |
| 81002 | <1% | 15 | $44.70 | |
| 97802 | <1% | 2,325 | $30.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 38 | $0.99 |
| 90680 | 0% | 1,444 | $0.00 | |
| 99174 | 0% | 2,425 | $0.00 | |
| 90723 | 0% | 167 | $0.00 | |
| 90698 | 0% | 1,050 | $0.00 | |
| 90647 | 0% | 532 | $0.00 | |
| 90651 | 0% | 469 | $0.00 | |
| 99000 | 0% | 285 | $0.00 | |
| 90688 | 0% | 760 | $0.00 | |
| 90744 | 0% | 341 | $0.00 | |
| 90696 | 0% | 135 | $0.00 | |
| 90716 | 0% | 291 | $0.00 | |
| 90619 | 0% | 76 | $0.00 | |
| 90670 | 0% | 1,744 | $0.00 | |
| 90734 | 0% | 389 | $0.00 | |
| 90671 | 0% | 895 | $0.00 | |
| 90710 | 0% | 254 | $0.00 | |
| 90700 | 0% | 121 | $0.00 | |
| 90633 | 0% | 1,114 | $0.00 | |
| 90687 | 0% | 204 | $0.00 | |
| 90707 | 0% | 223 | $0.00 | |
| 90715 | 0% | 161 | $0.00 | |
| 97803 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOND, DMYTRO (PRESIDENT)